Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

Yung-Yeh Su,1– 3,* Yi-Sheng Liu,4,* Chin-Fu Hsiao,5 Chiun Hsu,6– 8 Li-Tzong Chen1,2,9,10 1National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; 2Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng...

Full description

Bibliographic Details
Main Authors: Su YY, Liu YS, Hsiao CF, Hsu C, Chen LT
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
immunotherapy
liver-directed therapy
biomarker
Online Access:https://www.dovepress.com/trial-designs-for-integrating-novel-therapeutics-into-the-management-o-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/trial-designs-for-integrating-novel-therapeutics-into-the-management-o-peer-reviewed-fulltext-article-JHC

Similar Items